Long-term survival trends among adolescents and young adults (AYAs) with the cancer types with the highest mortality highlight areas where additional research is needed.
While the 5-year relative survival for multiple cancer types in adolescents and young adults (AYAs) has improved, there are some cancer types with limited improvements, according to a new study in Cancer. In addition, while there have been improvements in colorectal cancer, the incidence of this cancer has risen.
The authors used recent data to analyze the long-term survival trends for the cancer types with the highest mortality rates among AYAs. They used the Surveillance, Epidemiology, and End Results 18 registries to calculate 5-year relative survival for AYAs diagnosed with cancer between the ages of 15 and 39 years in 2009-2015. The National Center for Health Statistics was used to calculate US cancer mortality rates per 100,000 in 2012-2016.
They found that the incidence rate for AYAs diagnosed was 74.96 cases of cancer per 100,000 and the mortality rate of any cancer type was 9.01 deaths per 100,000. The 9 cancer types with the highest incidence rates were not the same as the 9 cancer types with the highest mortality rate.
The types with the highest mortality were female breast cancer; brain and other nervous system cancers; cervical cancer; colon and rectum cancer; bone, joint, and soft tissue sarcomas; ovarian cancer; lung and bronchus cancer; acute myeloid leukemia (AML); and non-Hodgkin lymphoma. Breast cancer had the highest incidence (22.41 cases per 100,000), while lung and bronchus cancer had the lowest (1.03 per 100,000).
The trend analysis found:
One of the key limitations to the study is that the mortality data only includes those who died of cancer between the ages of 15 and 39 years, and as a result, “do not perfectly reflect death rates among these individuals who were diagnosed between the ages of 15 and 39 years.” Some of the deaths include those diagnosed before the age of 15 years, and those who died in their 40s or later were not included.
“Our findings underscore the need for additional research to understand cancers showing poorer progress,” the authors concluded. “Substantial concern remains regarding the high number of breast cancers coupled with declining survival rates, the increases in colorectal cancer incidence, and the slow progress for sarcomas and AML, which suggest investigations of biological differences among AYA patients and efforts to further improve treatment in this group.”
Reference
Riedel Lewis D, Siembida EJ, Seibel NL, Wilder Smith A, Mariotto AB. Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975-2016. Cancer. Published online July 26, 2021. doi:10.1002/cncr.33793
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen